CVE:QPT Quest PharmaTech (QPT) Stock Price, News & Analysis C$0.04 -0.01 (-11.11%) As of 12:45 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsInsider TradesBuy This Stock About Quest PharmaTech Stock (CVE:QPT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Quest PharmaTech alerts:Sign Up Key Stats Today's RangeC$0.04▼C$0.0450-Day RangeC$0.02▼C$0.0652-Week RangeC$0.02▼C$0.06Volume113,000 shsAverage Volume85,827 shsMarket CapitalizationC$6.77 millionP/E RatioN/ADividend Yield6.15%Price TargetN/AConsensus RatingN/A Company OverviewQuest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.Read More… Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. Email Address QPT Stock News HeadlinesQuest PharmaTech Inc (QPT)November 1, 2024 | investing.comQuest PharmaTech Inc.: Quest PharmaTech Announces Results from AGMOctober 12, 2024 | finanznachrichten.deGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s already performing nearly twice as well as gold this year and looks ready to go much higher. If you wait for the news to hit, you’ll already be too late.May 2, 2025 | Golden Portfolio (Ad)Quest PharmaTech Inc.: Quest PharmaTech Announces Results from AGMOctober 12, 2024 | finanznachrichten.deQuest PharmaTech Announces Results from AGMOctober 11, 2024 | finance.yahoo.comQuest PharmaTech: Top 10 Undervalued Growth Stocks on TSX-V (QPT)August 11, 2024 | theglobeandmail.comQuest PharmaTech: Top 25 Undervalued TSX Venture Exchange Stocks (QPT)August 5, 2024 | theglobeandmail.comClosing Bell: Quest Pharmatech Inc up on Wednesday (QPT)May 26, 2024 | theglobeandmail.comSee More Headlines QPT Stock Analysis - Frequently Asked Questions How have QPT shares performed this year? Quest PharmaTech's stock was trading at C$0.03 on January 1st, 2025. Since then, QPT shares have increased by 33.3% and is now trading at C$0.04. View the best growth stocks for 2025 here. How do I buy shares of Quest PharmaTech? Shares of QPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Quest PharmaTech own? Based on aggregate information from My MarketBeat watchlists, some other companies that Quest PharmaTech investors own include Cameco (CCJ), Indiva (NDVA), Titan Medical (TMD), Aurinia Pharmaceuticals (AUP), Athenex (ATNX), Athersys (ATHX) and Antibe Therapeutics (ATE). Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:QPT CIKN/A Webwww.questpharmatech.com Phone+1-780-4481400FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,880,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-6.28% Return on Assets-1.07% Debt Debt-to-Equity Ratio4.35 Current Ratio0.40 Quick Ratio0.52 Sales & Book Value Annual SalesC$38,871.00 Price / Sales174.04 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueC$0.14 per share Price / Book0.29Miscellaneous Outstanding Shares169,130,000Free FloatN/AMarket CapC$6.77 million OptionableNot Optionable Beta0.14 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (CVE:QPT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quest PharmaTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.